ID
36219
Description
Study ID: 101468/201 Clinical Study ID: 101468/201 Study Title: A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of 21 Visits(Days): Screening (at least 21 days before dosing) Week 1: including Day 1-7 Week 2: including Day 8-14 Week 3: including Day 15-19 Follow-up Visit (7-14 days after last dose) This document contains the Eligibility criteria for. It has to be filled in for screening.
Mots-clés
Versions (2)
- 01/09/2017 01/09/2017 -
- 23/04/2019 23/04/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
23 avril 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Determination of starting dose and up-titration regimen for a new formulation of Ropinirole in healthy adults, 101468/201
Eligibility criteria
- StudyEvent: ODM
Description
Inclusion Criteria
Alias
- UMLS CUI-1
- C1512693
Description
Gender, Age
Type de données
boolean
Alias
- UMLS CUI [1]
- C0079399
- UMLS CUI [2]
- C0001779
Description
Body mass index
Type de données
boolean
Alias
- UMLS CUI [1]
- C1305855
Description
A subject with a clinical abnormality may be included only if the Principal Investigator, in agreement with the Sponsor, considers that the abnormality will not introduce additional risk factors and will not interfere with the study procedures.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0559229
- UMLS CUI [1,2]
- C1456356
Description
Subjects with laboratory values outside the reference range for this age group will only be included if the Principal Investigator considers that such findings will not introduce additional risk factors.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1298908
- UMLS CUI [1,2]
- C0438215
Description
12-lead ECG
Type de données
boolean
Alias
- UMLS CUI [1]
- C0430456
Description
Normal blood pressure
Type de données
boolean
Alias
- UMLS CUI [1]
- C0005823
Description
Informed consent
Type de données
boolean
Alias
- UMLS CUI [1]
- C0021430
Description
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Description
Number of cigarettes per day
Type de données
boolean
Alias
- UMLS CUI [1]
- C3694146
Description
Comorbidity cardiovascular, neurological, psychiatric, haematological or renal
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C3887460
- UMLS CUI [2,1]
- C0009488
- UMLS CUI [2,2]
- C0746866
- UMLS CUI [3,1]
- C0009488
- UMLS CUI [3,2]
- C0846574
- UMLS CUI [4,1]
- C0009488
- UMLS CUI [4,2]
- C0279810
- UMLS CUI [5,1]
- C0009488
- UMLS CUI [5,2]
- C0232804
Description
Postural hypotension, faints
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0020651
- UMLS CUI [1,2]
- C0039070
Description
Comorbidity Interferes with drug metabolism
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0521102
- UMLS CUI [1,3]
- C0521102
Description
Subjects who have taken OTC medication (apart from CYP1A2 medications, see below) may still be entered into the study, if, in the opinion of the Principal/Co-investigator in agreement with the Sponsor, the medication received will not interfere with the study procedures or compromise subjects’ safety.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0013227
Description
Hormone therapy
Type de données
text
Alias
- UMLS CUI [1]
- C0279025
Description
drug dose
Type de données
boolean
Alias
- UMLS CUI [1]
- C0678766
Description
Pregnancy; breast-feeding
Type de données
text
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
Females of child-bearing potential; method of contraception
Type de données
text
Alias
- UMLS CUI [1]
- C3831118
- UMLS CUI [2]
- C0700589
Description
Pregnancy test positive
Type de données
text
Alias
- UMLS CUI [1]
- C0240802
Description
Substance use disorder
Type de données
boolean
Alias
- UMLS CUI [1]
- C0038586
Description
One unit is equivalent to half a pint of beer, one measure of spirits or one glass of wine) or a positive screening or pre-dose alcohol test.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0085762
Description
Hepatitis B surface antigen hepatitis C antibody positive; HIV Antibodies
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0019168
- UMLS CUI [1,2]
- C0281863
- UMLS CUI [2]
- C0019683
Description
Study subject participation status; blood donation
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
- UMLS CUI [2]
- C0005794
Description
Hypersensitivity
Type de données
boolean
Alias
- UMLS CUI [1]
- C0020517
Similar models
Eligibility criteria
- StudyEvent: ODM
C0001779 (UMLS CUI [2])
C1456356 (UMLS CUI [1,2])
C0438215 (UMLS CUI [1,2])
C3887460 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0746866 (UMLS CUI [2,2])
C0009488 (UMLS CUI [3,1])
C0846574 (UMLS CUI [3,2])
C0009488 (UMLS CUI [4,1])
C0279810 (UMLS CUI [4,2])
C0009488 (UMLS CUI [5,1])
C0232804 (UMLS CUI [5,2])
C0039070 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
C0281863 (UMLS CUI [1,2])
C0019683 (UMLS CUI [2])
C0005794 (UMLS CUI [2])